Monday 6 November 2017

ARE WE OVERPRESCRIBING CEFOVECIN IN CATS?



 
        Oral therapy can be a challenge in some feline patients. The extended duration of Cefovecin’s coverage is very tempting. However, we should treat this drug as a second-line antimicrobial.


A recent study (1) shows a worrying number of highest priority critically important antimicrobial agents (HPCIA) prescriptions in cats in UK, compared with dogs (39.2% versus 5.4%). The most frequently prescribed antibiotic in cats is cefovecin (36.2%).

This antimicrobial has been included in the HPCIA by the World Health Organisation (WHO) (2). Its importance is related to the therapy of acute bacterial meningitis and disease due to Salmonella in children and infections due to MDR Enterobacteriaceae, which are increasing in incidence. The WHO also warns us that “resistance may result from transmission of Enterobacteriaceae, including E. coli and Salmonella, from non-human sources.”

 

 There are two uses in cats described on Convenia’s EU-data sheet:

1) Treatment of skin and soft tissue abscesses and wounds associated with specific bacterias.

Cat fight- abscesses may lead to multi-organ system failure as a consequence of septic shock or bacterial toxins. Anaerobes are most frequently isolated in abscesses (3) and cefovecin effect on these is poor (4). FECAVA antibiotic prescription guidelines recommends amoxicillin- clavulanic acid or clindamycin as empirical treatment of abscesses (5). Nowadays amoxicillin-clavulanic acid is available in palatable tables and clindamycin can be found in liquid form. It is also useful to remind ourselves that sometimes these abscesses can be managed with drainage and chlorhexidine flushing alone.

Bacterial pyoderma had been historically considered a rare finding in cats, possibly due to decreased bacterial adherence to corneocytes (6). A recent study (7) showed that feline pyoderma is not that uncommon, although its prevalence is still low when compared to dogs.  In this study feline pyoderma was frequently linked to underlying hypersensitivities, which need to be treated to effectively fight the pruritus (8). A significant part of these cats do not respond to antibiotic treatment. On the other hand, cytological criteria to guide diagnosis are not well defined (7), lesions are unspecific and treatment of feline pyoderma is frequently prescribed without previous cytology in first opinion practice. It would be interesting to find out how often we prescribe this antibiotic in cases of low bacterial risk.

 

2) Urinary tract infections (UTI) caused by E. Coli and Proteus.

Cefovecin is not active against Pseudomonas pp. or Enterococci and the latter are third in importance after E. Coli and Staphylococcus in feline UTI (9,10).

Bacterial cystitis is only present in a low percentage (2-12%) of young cats with urinary tract symptoms. In older cats and cats with predisposing diseases the prevalence of bacterial cystitis may be twice as much as in younger individuals (5). Feline idiopathic cystitis is responsible for a great number of low urinary tract disorders (FLUTD) in cats and should be considered first in our list of differential diagnosis.

The guidelines (5) recommend aminopenicillins for UTI treatment initiated before results are available, and amoxicillin/clavulanate in pyelonephritis. In-house tests can be used to achieve prompter culture and sensitivity results.

 
SOME PROPERTIES OF CEFOVECIN THAT WE DO NOT ALWAYS REMEMBER:
 
1)      Renal elimination, but a small amount is eliminated unchanged in the bile. It needs to be used with caution in animals with renal dysfunction and avoided when the dysfunction is severe (11). Conserations:
o   Decrease dose when CREA 2.5-3.5 mg/d (221-309 mmol/L)
§  Standard dose   x      (normal sCREA/cat sCREA)
§  Reduce dosing interval: CatsCREA/ normal sCREA
2)      Because the drug can persist in the body for up to 65 days, adverse reactions may occur that require prolonged treatment. Some specific adverse effects have been described in cats (11): odd behaviour, vocalisation, inappropriate urination, haemolytic anaemia and elevated BUN and serum creatinine.        
3)      The long duration of excretion in the urine makes it difficult to interpret post-treatment culture results.
4)      Although clinical significance has not been established, it may compete with other highly protein-bound drugs for plasma protein binding sites: furosemide, doxycycline, and ketoconazole, NSAIDs, propofol, cardiac, anticonvulsant, and behavioral medications.
5)      Light sensitive.
6)      Cefovecin may cause positive Coomb’s test, positive serum/urine creatinine (Jaffa) and urinary glucose (Clinitest).
 

On the study by Singleton’s et al, the main presenting complaints more likely to be associated with antibiotic prescription included respiratory conditions, trauma, tumours and kidney disease.

Let us have a look at the most common bacterial isolates in cats (12):

-          Systemic infections:

o   Neutropenia E. coli, Enterococcus spp., anaerobes

o   Systemic inflammatory response syndrome E. coli

-          Respiratory tract:

o   Upper respiratory tract infections: Mycoplasma spp., Chlamydophila felis, or Bordetella bronchiseptica.

o   Pneumonia Mycoplasma spp.

o   Pyothorax Pasteurella spp., anaerobes

-          Pyelonephritis E. coli, Enterococcus spp.

-          Cholangitis/Hepatitis Escherichia coli, Enterococcus spp., anaerobes.

Amoxicillin-clavulanic acid and doxycycline were reported to be more efficacious than cefovecin in shelter cats with clinical signs consistent with upper respiratory disease (13). Its high protein-binding does not allow it to achieve effective serum levels to treat systemic E. Coli infections (14). As discussed above, administration of this antimicrobial in cases of renal dysfunction should be carefully handled.

 So it seems like Cefovecin is overprescribed in cats, despite the fact that its long duration of action involves a potentially higher risks of adverse effects including the development of bacterial antimicrobial resistance.

International Cat Care tries to address the difficulties found in cats when oral treatment is administered by describing restraining techniques and providing a list of options such as pill crushers, gelatine capsules, pill splitters and pill givers. Detailed instruction can be found on their web site: https://icatcare.org/advice/how-give-your-cat-tablet

Besides that, there are a few antibiotics available which make administration easier and more palatable (e.g: Zodon (liquid clindamycin), Synulox palatable tablets) as well as treats to wrap drugs up (Easypill).

 

References:

  1. Singleton, D.A. et al. Patterns of antimicrobial agent prescription in a sentinel population of canine and feline veterinary practices in the United Kingdom. The Veterinary Journal, 224(June), pp. 18-24 2017
  2. Critically important antimicrobials for human medicine – 5th rev. Geneva: World Health Organization; 2017.
  3. Love et al Bacteriological warfare amongst cats: what have we learned about cat bite infections? Veterinary Microbiology 74 179-193  2000
  4. Wiebe, V. Drug Therapy for Infectious Diseases of the Dog and Cat. Table 3.1. Section A: Pharmacology guidelines. Chapter 4:  Approaching infectious diseases cases p 3  Ed: Wiley-Blackwell 2015
  5. FECAVA/Danish Small Animal Veterinary Association Antibiotic Use Guidelines for Companion Animal Practice. Chapter 6: Organ and disease specific recommendations 2009
  6. Woolley, K.L.; Kelly, R.F.; Fazakerley, J.; Williams, N.J.; Nuttall, T.J.; McEwan, N.A. Reduced in vitro adherence of Staphylococcus species to feline corneocytes compared to canine and human corneocytes. Vet. Dermatology. 19, 1–6 2008,
  7. YU H. W. and Vogelnest L. J. Feline superficial pyoderma: a retrospective study of 52 cases (2001-2011) Veterinary dermatology p1-10 2012
  8. Diesel, A. Cutaneous hypersensitivity dermatoses in the feline patient: a review of allergic skin disease in cats Veterinary Science 4(2), 25 2017
  9. Marques et al. European multicenter study on antimicrobial resistance in bacteria isolated from companion animal urinary tract infections. Veterinary Research 12:213 2016
  10. Litster A, Moss S, Platell J et al.: Occult bacterial lower urinary tract infections in cats - urinalysis and culture findings. Veterinary Microbiology 136(1-2):130-134, 2009
  11. Katrina R. Viviano. Chapter 4: Practical Antimicrobial Therapy. Consultations in Feline Internal Medicine Vol 7 edited by S.E Little. Ed Elsevier p57 2016
  12. Maddison J, Page S, Church D. Clinical Conditions in Cats Associated with Bacterial Infections and the Most Common Bacterial Isolates to Guide Empirical Antimicrobial Therapy Small animal clinical pharmacology, Edinburgh, Saunders. 2008
  13. Litster AW: Comparison of the efficacy of amoxicillin-clavulanic acid, cefovecin and doxycycline in the treatment of upper respiratory disease in cats housed in animal shelters. Am Vet Med Assoc 241:218-226, 2012
  14. Wiebe, V. Drug Therapy for Infectious Diseases of the Dog and Cat.  Section D: Antibiotics Chapter 135:  Cefovecin p 136  Ed: Wiley-Blackwell 2015

 

 

No comments:

Post a Comment